Skip to main content
. Author manuscript; available in PMC: 2017 Jun 14.
Published in final edited form as: Cancer. 2017 Mar 3;123(11):1989–1997. doi: 10.1002/cncr.30649

TABLE 2.

Baseline and Follow-Up Results for the Primary and Secondary Time Points: Treatment Versus Control

Measure Mean (SE)
Pa Effect Sizeb
Treatment (n = 30)
Control (n = 32)
Baseline Follow-Up Change Baseline Follow-Up Change
Brief Pain Inventory
 Worst pain 6.00 (0.40) 3.57 (0.44) −2.40 (0.56) 5.53 (0.45) 5.62 (0.43)   0.09 (0.40) .001 0.83
 Average pain 4.90 (0.35) 2.70 (0.38) −2.20 (0.50) 4.38 (0.44) 4.50 (0.35)   0.13 (0.33) .001 0.88
 Pain interference 3.35 (0.30) 1.49 (0.30) −1.86 (0.42) 2.92 (0.24) 2.90 (0.45) −0.02 (0.40) .009 0.66
 Pain severity 4.70 (0.27) 2.70 (0.38) −2.00 (0.46) 4.58 (0.27) 4.25 (0.36) −0.33 (0.38) .001 0.77
 Activity interference 4.15 (0.33) 1.80 (0.31) −2.35 (0.46) 3.71 (0.27) 3.59 (0.51) −0.12 (0.48) .001 0.76
 Affective interference 2.74 (0.31) 1.25 (0.32) −1.50 (0.42) 2.33 (0.25) 2.39 (0.44) 0.06 (0.39) .042 0.51
PQAS
 Unpleasantness 6.43 (0.36) 3.17 (0.43) −3.27 (0.49) 6.39 (0.37) 5.74 (0.40) −0.65 (0.30) .000 1.17
 Numbness 6.53 (0.51) 2.90 (0.44) −3.63 (0.47) 6.67 (0.52) 5.68 (0.50) −1.00 (0.47) .000 1.09
 Tingling 6.19 (0.56) 2.84 (0.39) −3.35 (0.49) 6.61 (0.49) 5.64 (0.42) −0.10 (0.39) .000 1.25
 Intensity 5.90 (0.38) 3.52 (0.40) −2.39 (0.49) 5.27 (0.46) 5.87 (0.39) −0.60 (0.41) .001 0.73
 Tenderness 4.40 (0.45) 1.17 (0.26) −3.20 (0.48) 3.68 (0.56) 3.84 (0.50)   0.16 (0.54) .000 1.19
 Surface pain 4.90 (0.53) 2.65 (0.40) −2.25 (0.55) 5.42 (0.44) 6.00 (0.41) −0.55 (0.38) .000 1.33
 Deep pain 4.23 (0.37) 1.42 (0.22) −2.81 (0.38) 3.88 (0.43) 3.50 (0.42) −0.38 (0.30) .000 1.10
 Sensitive 3.23 (0.43) 1.27 (0.25) −1.96 (0.55) 3.77 (0.60) 3.13 (0.54) −0.65 (0.63) .004 0.78
 Itchy   2.0 (0.49) 0.73 (0.24) −1.27 (0.36) 1.52 (0.46) 2.06 (0.52)   0.55 (0.47) .003 0.59
 Sharp 4.35 (0.51) 2.16 (0.43) −2.19 (0.54) 4.25 (0.52) 4.00 (0.55) −0.26 (0.32) .001 0.67
 Hot 2.71 (0.44) 1.00 (0.30) −1.71 (0.39) 2.19 (0.55) 2.16 (0.47) −0.03 (0.33) .001 0.53
 Dull 4.16 (0.56) 2.45 (0.35) −1.71 (0.54) 4.81 (0.46) 3.94 (0.44) −0.87 (0.58) .017 0.67
 Cold 3.64 (0.61) 1.45 (0.39) −2.19 (0.50) 2.58 (0.54) 3.25 (0.63)   0.68 (0.37) .000 0.62
 Shooting 3.77 (0.61) 1.27 (0.35) −2.50 (0.55) 3.71 (0.54) 3.90 (0.56)   0.19 (0.41) .000 1.02
 Electrical 3.53 (0.62) 1.67 (0.41) −1.87 (0.69) 3.45 (0.62) 3.77 (0.53)   0.32 (0.70) .002 0.80
 Cramping 4.71 (0.58) 1.68 (0.40) −3.03 (0.57) 3.70 (0.62) 3.13 (0.53) −0.55 (0.52) .002 0.56
 Radiating 4.10 (0.58) 0.65 (0.22) −3.45 (0.58) 3.65 (0.53) 3.19 (0.55) −0.45 (0.35) .000 1.10
 Throbbing 3.42 (0.57) 0.81 (0.28) −2.61 (0.46) 3.71 (0.63) 3.77 (0.60)   0.06 (0.47) .000 1.13
 Aching 4.55 (0.54) 0.90 (0.25) −3.65 (0.48) 3.68 (0.55) 3.32 (0.55) −0.35 (0.56) .000 1.02
 Heavy 4.29 (0.66) 1.26 (0.37) −3.03 (0.61) 3.55 (0.58) 3.35 (0.60) −0.19 (0.47) .000 0.75

Abbreviations: PQAS, Pain Quality Assessment Scale; SE, standard error.

a

P values were acquired from a general linear model.

b

Effect sizes were calculated on the basis of group differences in change scores from the pretraining period to the posttraining period with Cohen’s d.